The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease
NACompletedINTERVENTIONAL
Enrollment
28
Participants
Timeline
Start Date
January 31, 2000
Primary Completion Date
April 30, 2007
Study Completion Date
April 30, 2007
Conditions
Cytomegalovirus
Interventions
DRUG
CMV Immune globulin
CMV IvIg 150mg/kg x 6 doses
Trial Locations (1)
53792
University of Wisconsin, Madison
All Listed Sponsors
lead
University of Wisconsin, Madison
OTHER
NCT00214240 - The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease | Biotech Hunter | Biotech Hunter